This approach generated neuronal grafts with significantly altered transcriptome profiles in APPV717I neurons that recapitulate synaptic function-related transcriptomic dysregulation of AD with identification of potential therapeutic targets, including the transmembrane protein LINGO2, as demonstrated by comparative single cell analysis using single nucleus RNA-sequencing (snRNA-seq). Here, LINGO2 is linked to Alzheimer disease.